catalpol has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, X; Li, Y; Ren, H; Wang, D; Yuan, G; Zhang, L; Zhou, X | 1 |
| Dong, D; Jin, Y; Liu, K; Liu, Q; Lu, J; Ma, X; Meng, Q; Sun, H; Wang, C; Xu, C; Zhang, Y | 1 |
2 other study(ies) available for catalpol and Liver Steatosis
| Article | Year |
|---|---|
Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Diet, High-Fat; Disease Models, Animal; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Iridoid Glucosides; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Obesity; Phytotherapy; Rehmannia | 2019 |
Targeting of miR-96-5p by catalpol ameliorates oxidative stress and hepatic steatosis in LDLr-/- mice via p66shc/cytochrome C cascade.
Topics: Animals; Cytochromes c; Diet, Western; Fatty Liver; Iridoid Glucosides; Liver; Mice; Mice, Knockout; MicroRNAs; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Receptors, LDL; Src Homology 2 Domain-Containing, Transforming Protein 1 | 2020 |